Last updated 2026-09-02
- Acquired LightSolver Ltd., Aug 2026
- Raised $3.7M Undisclosed Round led by Rodman & Renshaw LLC, Oct 2026
- Raised $2.6M Follow-on PO led by H.C. Wainwright & Co., Feb 2026
Total raised
$6.3M
Stage
Public
Founded
—
Headcount
39
HQ
Rehovot, Israel
Sector
Biotechnology
About
CollPlant is a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing. Their products are based on type I recombinant human collagen (rhCollagen), which is genetically and structurally identical to the collagen naturally produced by the human body. This plant-based technology allows for mass production of rhCollagen, which is used as a building block for various regenerative medicine applications, including tissue engineering and organ manufacturing.
Funding history · 2 rounds · $6.3M total
2 events/rounds · $6.3M Total Funding: $3.7M in Private Equity, $2.6M in Public Equity
Oct 2026
★ Rodman & Renshaw LLC★ H.C. Wainwright & Co.
Feb 2026
★ H.C. Wainwright & Co.
Acquisitions · 1
Aug 2026
LightSolver Ltd.
Undisclosed
Headcount over time
39 employees (2026-09) · 1 point
Offices
Rehovot, Israel · HQ / main office
Q&A
- What is CollPlant Biotechnologies' primary focus?
- CollPlant Biotechnologies is an Israeli regenerative medicine company focused on 3D bioprinting of tissues and organs.
- What is CollPlant Biotechnologies' proprietary technology?
- CollPlant Biotechnologies' proprietary rhCollagen (recombinant human collagen) is produced using plant-based technology.
- What are the applications of CollPlant Biotechnologies' rhCollagen?
- CollPlant Biotechnologies' rhCollagen is used in 3D bioprinting of tissues and organs, as well as in dermal fillers and other medical applications.
- In which sector does CollPlant Biotechnologies primarily operate?
- CollPlant Biotechnologies operates in the Health Tech & Life Sciences sector.
- What is the current status of CollPlant Biotechnologies?
- CollPlant Biotechnologies is a public company.
- What technologies does CollPlant Biotechnologies utilize?
- CollPlant Biotechnologies utilizes 3D Bioprinting, Regenerative Medicine, and Recombinant Human Collagen technologies.
- Which company did CollPlant Biotechnologies acquire?
- CollPlant Biotechnologies acquired LightSolver Ltd. in August 2026.
Team · 7
Oded Shoseyov
Founder · CTO Director
Yehiel Tal
CEO & Chairman
Eran Rotem
Deputy CEO & CFO
Elan Penn
Independent Director
Abraham Havron
Independent Director
Ofer Levy
Member of the Scientific Advisory Board & Member of the Clinical Advisory Board
Shay Soker
Member of Advisory Board
Sectors & technology
Primary sector
Biotechnology
Technologies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | collplant.com |
|---|
Identifiers & details
| Legal name | CollPlant Biotechnologies Ltd. |
|---|---|
| Employees (exact) | 39 |
Acquisitions & public offerings
| Acquired | Date | Amount |
|---|---|---|
| LightSolver Ltd. | 2026-08 |